Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102633802B details a scalable 3-step route for 2-chloro-7H-pyrrolo[2,3-d]pyrimidine, offering significant cost reduction and simplified purification for API manufacturing.
Patent CN112047829B reveals a cost-effective Grignard carboxylation route for high-purity Alectinib intermediates, offering significant supply chain advantages.
Novel patent CN108623577A offers high-yield Amonebvir intermediate synthesis. Reduces steps, avoids protecting groups, ensures supply chain stability for pharmaceutical manufacturing.
Patent CN106380466B details a high-purity cobalt-catalyzed route. Offers supply chain stability and cost efficiency for pharmaceutical intermediate manufacturing globally.
Patent CN101319236A details a green biocatalytic method for chiral alcohols using ionic liquids. Achieve high purity and cost reduction in pharma intermediate manufacturing with scalable processes.
Patent CN116554056A reveals a novel one-pot base-catalyzed route for cyclohexane derivatives, offering significant cost reduction in fine chemical manufacturing and high-purity outcomes.
Patent CN113429349B details a novel Cu/g-C3N4 catalyzed route for 2-trifluoromethyl benzimidazoles, offering mild conditions and recyclable catalysts for cost-effective manufacturing.
Novel biocatalytic route for chiral alcohol intermediates ensures >99% ee and scalable production for beta-3 agonists.
Patent CN112047829B reveals a cost-effective Grignard carboxylation route for high-purity Alectinib intermediates, offering significant supply chain advantages.
Novel one-pot synthesis for Montelukast Sodium ensures high purity and yield. Ideal for reliable API intermediate suppliers seeking cost-effective manufacturing solutions.
Patent CN104402790A reveals a safer Ezetimibe route. Eliminating silyl protection reduces toxicity and cost for reliable API intermediate supply.
Advanced manufacturing route for Vilazodone intermediates utilizing microwave cyanation and efficient piperazine cyclization, offering high purity and scalable production for pharmaceutical supply chains.
Patent CN101602713B reveals a novel alkaline hydrolysis route for 2-chloronicotinic acid, offering 93% yield and significant cost reduction in agrochemical intermediate manufacturing.
Patent CN117304194B details a safer Upadacitinib synthesis route. Achieve high purity and cost reduction in pharma manufacturing with scalable intermediates.
Patent CN106748605A details a green TBAB-Oxone method for o-dicarbonyl compounds, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN117304194B details a safer high-yield route for JAK inhibitor production reducing hazardous reagents and enhancing supply chain stability for global procurement.
Patent CN107778271A details a scalable CX1409 synthesis avoiding chromatography. This method offers significant cost reduction and supply chain reliability for global buyers.
Novel Pd-catalyzed route for penta-hepta-homopiperazinone derivatives offers high yield and mild conditions for scalable API intermediate production.
Novel NBS-mediated synthesis of alpha-1,3,5-triazinethioketones offers high purity and cost-effective manufacturing for anti-tumor drug development pipelines.
Patent CN116356354A reveals a green electrochemical route for 2-aryl-3-sulfonyl compounds, offering cost reduction in API manufacturing and reliable supply chain solutions.